Identification of Critical Thermal Environments for Aged Adults

The earth's climate is warming well above historical averages, and there is an increased frequency, duration, and severity of heat waves. At the same time, the world's population is rapidly aging. Aging is associated with reductions in thermoregulatory capacity due to reductions in sweating and skin blood flow. For this reason, people ≥65 years exhibit exponentially larger increases in morbidity and mortality during heat waves than younger individuals, with the large majority of excess deaths during heat waves occurring in the elderly.

Compounding the physiological effects of primary aging, co-morbidities and common classes of drugs taken by older adults can further compromise their thermoregulatory function. One such class of medications is cyclooxygenase inhibitors, including aspirin (ASA) and other platelet inhibitors. Provocative data published by our lab indicate that platelet inhibitors including ASA increase the rate of heat storage during passive heat stress by ~25%. Following current clinical guidelines, nearly 40% of US adults over the age of 50 engage in an aspirin therapy regiment for the primary or secondary prevention of cardiovascular disease.

Although there is compelling evidence that aging is associated with decreased heat dissipation and elevated risk of heat illness in hot ambient conditions, the significant question remains: In what specific environments does this age disparity begin to occur? The goal of the current study is to identify and model ambient conditions that are unsafe for older adults. A second aim of the study is to determine the effects of the commonly used platelet inhibitor, acetylsalicylic acid (ASA), on age-specific critical environmental limits.

Inclusion criteria

• Adults aged 18 and older (those 40+ years of age must be cleared by collaborating physician)
• All premenopausal women will be eumenorrheic (by survey)
• Asymptomatic and no signs/symptoms of disease according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription

Exclusion criteria

• Medications that affect thermoregulatory or cardiovascular responses to exercise
• Any contraindications to low intensity physical activity on the Physical Activity Readiness Questionnaire
• Any mobility restrictions that interfere with low intensity physical activity
• Pregnant or planning to become pregnant in the next 12 months
• Prior diagnosis of cancer, cardiovascular disease, diabetes, or metabolic syndrome
• Illegal/recreational drug use
• History of Chron's disease, diverticulitis, or similar gastrointestinal disease
• Abnormal resting or exercise electrocardiogram (ECG)